A study comparing safety and efficacy of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir in patients with chronic hepatitis C
Latest Information Update: 10 Dec 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary) ; Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2020 New trial record